Delivery Order SPE2DB22D2009-SPE2DB25FL9AQ

Award Date 4/30/25
Potential Completion Date 5/1/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,869.15, is for the delivery of Myrbetriq ER 25 mg tablets. It is a firm fixed-price contract with an ultimate completion date of May 17, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Myrbetriq ER 50 mg tablets. The contract has a firm fixed price of $11,155.44 and a completion date of February 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Myrbetriq ER 50 mg tablets. The $1,457.41 firm fixed-price contract has a completion date of September 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of medical...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Myrbetriq ER 25 mg tablets, with a ceiling value of $5,955.76 and a period of performance through April 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $26,024.80 firm-fixed-price contract is for the delivery of 4,568,108,345 units of the pharmaceutical product Myrbetriq ER 50 mg tablets. The contract has a performance period through May 2, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,966,780 tablets of the medication Myrbetriq ER 25 mg, with a ceiling value of $9,957.69. The contract type is Firm Fixed Price and the pricing type is Firm Fixed Price. The place of performance is Conshohocken, Pennsylvania. This contract is not a set-aside and was competitively awarded....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of the medication Myrbetriq ER 25 mg tablets. The contract has a ceiling value of $2,669.34 and a period of performance through July 31, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Myrbetriq ER 50 MG Tablets in quantities of 90 per bottle. The contract has a firm fixed price of $4,689.40 and an ultimate completion date of March 6, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Myrbetriq ER 50 mg tablets. The contract, valued at $12,256.09, is a firm fixed-price, non-set-aside contract with an ultimate completion date of April 10, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,350.57, is for the supply of Myrbetriq ER 50 MG tablets. The order has an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FL9AQ
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,568,092,995 units of the medication Myrbetriq ER 25 mg Tablet. The contract has a firm fixed price of $11,955.09 and an ultimate completion date of May 1, 2025. The contract is not designated as a set-aside and is an open competition. AmerisourceBergen Drug Corp is the prime contractor, and the contract is associated with the company's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026.

Generated 8/3/25, 1:00 AM